Tögel M, Wiche G, Propst F
Institute of Biochemistry and Molecular Cell Biology, Vienna Biocenter, University of Vienna, A-1030 Vienna, Austria.
J Cell Biol. 1998 Nov 2;143(3):695-707. doi: 10.1083/jcb.143.3.695.
Previous studies on the role of microtubule-associated protein 1B (MAP1B) in adapting microtubules for nerve cell-specific functions have examined the activity of the entire MAP1B protein complex consisting of heavy and light chains and revealed moderate effects on microtubule stability. Here we have analyzed the effects of the MAP1B light chain in the absence or presence of the heavy chain by immunofluorescence microscopy of transiently transfected cells. Distinct from all other MAPs, the MAP1B light chain-induced formation of stable but apparently flexible microtubules resistant to the effects of nocodazole and taxol. Light chain activity was inhibited by the heavy chain. In addition, the light chain was found to harbor an actin filament binding domain in its COOH terminus. By coimmunoprecipitation experiments using epitope-tagged fragments of MAP1B we showed that light chains can dimerize or oligomerize. Furthermore, we localized the domains for heavy chain-light chain interaction to regions containing sequences homologous to MAP1A. Our findings assign several crucial activities to the MAP1B light chain and suggest a new model for the mechanism of action of MAP1B in which the heavy chain might act as the regulatory subunit of the MAP1B complex to control light chain activity.
先前关于微管相关蛋白1B(MAP1B)在使微管适应神经细胞特异性功能方面作用的研究,检测了由重链和轻链组成的整个MAP1B蛋白复合物的活性,并揭示了其对微管稳定性的适度影响。在此,我们通过对瞬时转染细胞进行免疫荧光显微镜观察,分析了在有无重链情况下MAP1B轻链的作用。与所有其他微管相关蛋白不同,MAP1B轻链可诱导形成稳定但明显具有柔韧性的微管,这些微管对诺考达唑和紫杉醇的作用具有抗性。轻链活性受到重链的抑制。此外,发现轻链在其COOH末端含有一个肌动蛋白丝结合结构域。通过使用MAP1B的表位标记片段进行的共免疫沉淀实验,我们表明轻链可以二聚化或寡聚化。此外,我们将重链-轻链相互作用结构域定位到含有与MAP1A同源序列的区域。我们的研究结果赋予了MAP1B轻链若干关键活性,并提出了一个关于MAP1B作用机制的新模型,其中重链可能作为MAP1B复合物的调节亚基来控制轻链活性。